|
|
Article: FDA issues approvable letter for AMBIEN CR CIV for the treatment of insomnia.(Industry News)
- Article from:
- Pharmaceutical Processing
- Article date:
- May 1, 2005
CopyrightCOPYRIGHT 2005 Advantage Business Media. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Sanofi-aventis recently announced that it had received an approvable letter from the FDA for AMBIEN CR (zolpidem tartrate extended release) CIV. AMBIEN CR[TM] is the controlled-release formulation of zolpidem, a leading sleep aid.
An approvable letter outlines specific questions that have to be ...